Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
LEXICON PHARMACEUTICALS, INC. (LXRX)
Sector: Healthcare; Industry: Biotechnology

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-15 Tessmer James F VP, Finance & Accounting Sell 22,912 $6.92 $158,440 Yes
2019-08-02 Tessmer James F VP, Finance & Accounting Buy 10,000 $1.14 $11,400 No
2018-06-08 Tessmer James F VP, Finance & Accounting Sell 10,000 $12.91 $129,076 Yes
2016-06-06 Tessmer James F VP, Finance & Accounting Sell 1,500 $15.00 $22,500 Yes
2016-05-23 Tessmer James F VP, Finance & Accounting Sell 6,000 $13.00 $78,000 Yes

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.